Stifel Raises Marvell Price Target to $120

Mar 6, 2026· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$120
Previous
$114
Implied upside
+59%

Stifel analyst Tore Svanberg raised the price target on Marvell Technology (NASDAQ: MRVL) to $120.00 (from $114.00) while maintaining a Buy rating.

“Slight Jan Q beat with revenue of $2.22bn (+7.0% q/q) coming in +0.8% vs. our $2.20bn estimate, driven by strong demand across the Data Center segment (+9% q/q), while Communications & Other grew +2% q/q.

Raised Apr Q outlook, with $2.40bn revenue midpoint (+8.2% q/ q) +4.9% vs. our prior $2.29bn estimate, with anticipated Data Center growth expected to continue leading the way.

We believe today’s print provides validation of Marvell’s execution and investments, supported by its meaningfully higher guide for FY27/28E.

We believe the business is clearly inflecting, providing meaningful validation of Marvell’s execution considering the heightened investor debate surrounding the stock in recent months.

We reiterate our Buy rating with a raised 12-month Target Price of $120 (from $114), representing a 22.4x CY27E P/E multiple.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.